Results 371 to 380 of about 217,476 (395)

Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas

Nature Biotechnology, 2020
Reuben Moncada, Dalia Barkley, Florian Wagner   +2 more
exaly  

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Nature Reviews Cancer, 2022
Mathilde Matthea Machteld Almekinders, Charlotta Mulder, Deborah Collyar   +2 more
exaly  

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

Nature Reviews Clinical Oncology, 2020
Won Jin Ho, Elizabeth M Jaffee, Lei Zheng   +2 more
exaly  

Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)

Ca-A Cancer Journal for Clinicians, 2002
Monica Morrow
exaly  

Challenges in ductal carcinoma in situ risk communication and decision‐making

Ca-A Cancer Journal for Clinicians, 2012
Ann H Partridge
exaly  

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Signal Transduction and Targeted Therapy, 2020
Xunbin Wei, Shengyu Yang, Jihui Hao
exaly  

Pancreatic Ductal Adenocarcinoma

2023
Anushri Parakh, Yoshifumi Noda, Avinash R. Kambadakone, Dushant V. Sahani   +3 more
openaire   +1 more source

Cancer statistics: Breast cancer in situ

Ca-A Cancer Journal for Clinicians, 2015
Otis W Brawley
exaly  

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Nature Reviews Cancer, 2010
Sam C Wang, Matthias Hebrok
exaly  

Acinar cell plasticity and development of pancreatic ductal adenocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2017
Peter Storz
exaly